EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Effect of Testosterone Treatment on Leucocyte Telomere Length in Men: Results From a Randomised Placebo‐Controlled Trial

Bu B Yeap iD, Jennie Hui iD, Kristy P Robledo iD, Gillian Arscott iD, Mathis Grossmann iD, David J Handelsman iD, Warrick J Inder iD, Bronwyn G A Stuckey iD, Alicia J Jenkins iD, Karen Bracken iD, John P Beilby, Gary A Wittert iD

Andrology · 2026-08-14

DOI: 10.1111/andr.70348 ↗

At a glance

Journal article in Andrology, published online on 2026-08-14. Written by Bu B Yeap and 11 co-authors. Institution: Medical School, University of Western Australia, Perth, Australia. 36 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Health and Medical Research Council, University of Adelaide, Weight Watchers and Sonic Healthcare.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Lower testosterone concentrations in older men are associated with poorer health outcomes.

Objective

We examined whether, on a background of lifestyle intervention, testosterone treatment modulates leucocyte telomere length, a postulated marker of biological ageing, in overweight men with impaired glucose tolerance (IGT) or newly diagnosed type 2 diabetes (T2D). Participants and Methods We conducted a secondary analysis of a randomised, placebo‐controlled trial in 50‐ to 74‐year‐old men with waist circumference ≥ 95 cm and dysglycaemia (ACTRN12612000287831). All men received a background lifestyle program, and were randomised to 2 years treatment with intramuscular testosterone undecanoate (1000 mg) every 3 months or placebo. Leucocyte telomere length was assayed by multiplex quantitative polymerase chain reaction and expressed as relative telomere length (rTL), a ratio of telomeric DNA to β‐globin, a single‐copy control gene (T/S ratio).

Results

There were 720 participants, aged 60 ± 6 years (mean ± SD), 38% had BMI 30–34.99 kg/m 2 and 44% ≥ 35 kg/m 2 . Mean rTL at baseline was 1.63 ± 0.27 in testosterone‐treated men ( N = 375) and 1.61 ± 0.28 in placebo‐treated men ( N = 345). At 2 years, mean rTL was 1.61 ± 0.28 and 1.58 ± 0.29, respectively. Change in rTL after 2 years treatment was −0.02 ± 0.15 in testosterone‐treated and −0.03 ± 0.12 in placebo‐treated men. Adjusting for baseline values there was no effect of testosterone treatment on rTL at 2 years (mean difference 0.01 [95% CI, −0.01 to 0.03], p = 0.24). Results were similar for rTL change at 2 years from baseline.

Conclusions

There was no effect of testosterone treatment on telomere length in this group of men. Larger studies with longer treatment durations are merited.

Subjects

Author keywords

malesrandomised controlled trialtelomeretestosteronetype 2 diabetes mellitus

Authors and institutions

  • Medical School, University of Western Australia, Perth, Australia.
  • Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Perth, Australia.
  • PathWest Laboratory Medicine, Sir Charles Gairdner Hospital, Perth, Australia.
  • School of Population and Global Health, University of Western Australia, Perth, Australia.
  • NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
  • Department of Medicine (Austin Health), University of Melbourne, Melbourne, Australia.

ORCID profiles: Bu B Yeap, Jennie Hui, Kristy P Robledo, Gillian Arscott, Mathis Grossmann, David J Handelsman, Warrick J Inder, Bronwyn G A Stuckey, Alicia J Jenkins, Karen Bracken, Gary A Wittert

Funding

  • National Health and Medical Research Council
  • University of Adelaide
  • Weight Watchers and Sonic Healthcare
  • Bayer
  • Lilly
  • Eli Lilly and Company

Cite

APA

Yeap, B. B., Hui, J., Robledo, K. P., Arscott, G., Grossmann, M., Handelsman, D. J., Inder, W. J., Stuckey, B. G. A., Jenkins, A. J., Bracken, K., Beilby, J. P., & Wittert, G. A. (2026). Effect of Testosterone Treatment on Leucocyte Telomere Length in Men: Results From a Randomised Placebo‐Controlled Trial. Andrology. https://doi.org/10.1111/andr.70348

Vancouver

Yeap BB, Hui J, Robledo KP, Arscott G, Grossmann M, Handelsman DJ, et al. Effect of Testosterone Treatment on Leucocyte Telomere Length in Men: Results From a Randomised Placebo‐Controlled Trial. Andrology. 2026. doi:10.1111/andr.70348

BibTeX
@article{Yeap2026,
  author = {Yeap, Bu B and Hui, Jennie and Robledo, Kristy P and Arscott, Gillian and Grossmann, Mathis and Handelsman, David J and Inder, Warrick J and Stuckey, Bronwyn G A and Jenkins, Alicia J and Bracken, Karen and Beilby, John P and Wittert, Gary A},
  title = {Effect of Testosterone Treatment on Leucocyte Telomere Length in Men: Results From a Randomised Placebo‐Controlled Trial},
  journal = {Andrology},
  year = {2026},
  doi = {10.1111/andr.70348}
}
Start for free →